Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

55
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
55
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

1.0K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deep Learning Enables Pixel-Level Nanoparticle Distribution Mapping in Routine Histological Sections by Integrating Cancer Associated Fibroblasts Features.

ACS nano·2026
Same author

An <sup>124</sup>I-radiolabeled exosome-based treatment platform for enhanced boron neutron capture therapy: precise delivery and real-time PET tracking of boron.

Nanoscale·2026
Same author

Structure-to-Therapeutic Transformation of Nanohydrogels Triggers Calcium Overload for Potentiated Boron Neutron Capture Therapy.

ACS nano·2026
Same author

Role of transforming growth factorβ in neurovascular unit during cerebral small vessel disease.

Fluids and barriers of the CNS·2025
Same author

Adenylosuccinate Synthase 1 Deficiency Improves Energy Metabolism by Promoting Adipose Tissue Re-esterification via Glycerol Kinase Upregulation.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same author

Morphine Tolerance Gated through EZH2-Mediated Suppression of Trpc5 in Spinal GABAergic Interneurons in Male Mice.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025

Related Experiment Video

Updated: Oct 12, 2025

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
14:10

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation

Published on: December 15, 2010

16.1K

Thrombolytic Agents: Nanocarriers in Targeted Release.

Minghua Shen1, Yujiao Wang2,3, Fan Hu2

  • 1Department of Biochemistry and Molecular Biology, Yanbian University Medical College, Yanji 133002, China.

Molecules (Basel, Switzerland)
|November 27, 2021
PubMed
Summary

Targeted nano-drug delivery systems offer a promising solution to overcome the limitations of current thrombolytic therapies for cardiovascular diseases. This review explores recent advancements in developing these novel systems for effective blood clot treatment.

Keywords:
biological nano-drug delivery systemnano-drug delivery systemphysical responsive nano-drug delivery system

More Related Videos

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

22.2K
Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli
13:10

Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli

Published on: September 25, 2016

10.1K

Related Experiment Videos

Last Updated: Oct 12, 2025

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
14:10

Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation

Published on: December 15, 2010

16.1K
Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

22.2K
Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli
13:10

Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli

Published on: September 25, 2016

10.1K

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Cardiovascular Medicine

Background:

  • Thrombosis, or blood clots, is a primary cause of cardiovascular diseases, leading to significant morbidity and mortality.
  • Existing thrombolytic drugs like urokinase and streptokinase have limitations, including short half-lives, adverse effects, and poor targeting.

Purpose of the Study:

  • To review recent advancements in targeted nano-drug delivery systems for thrombosis treatment.
  • To highlight how nanotechnology can overcome the shortcomings of conventional thrombolytic agents.

Main Methods:

  • Review of current literature on nano-drug delivery systems for thrombolysis.
  • Analysis of biological and physical responsive nano-systems.
  • Focus on targeted approaches for improved drug delivery.

Main Results:

  • Nano-drug delivery systems show potential to enhance thrombolytic therapy efficacy.
  • Targeted systems can improve drug concentration at the clot site and reduce systemic side effects.
  • Various responsive nano-carriers are being developed for precise thrombus targeting.

Conclusions:

  • Targeted nano-drug delivery represents a significant advancement in managing thrombosis.
  • Nanotechnology offers a viable strategy to improve the safety and effectiveness of cardiovascular disease treatments.
  • Further research into these systems is crucial for clinical translation.